Dr Gideon Hirschfield discusses some of the highlights on primary biliary cholangitis from The Liver Meeting 2023, with a focus on the RESPONSE trial of seladelpar.
Menu
Dr Gideon Hirschfield discusses some of the highlights on primary biliary cholangitis from The Liver Meeting 2023, with a focus on the RESPONSE trial of seladelpar.
This program is made possible thanks to an independent educational grant from Ipsen.
Email: IME@springer.com
Your feedback helps us create the most relevant independent programs for your learning needs in the future.